Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.
A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say. To be sure, drugs such as$諾和諾德 (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...
Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.
Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.
These are the top stocks as ranked by a growth model that scores companies based on a 50/50 weighting of their most recent quarterly year-on-year (YOY) percentage revenue growth and their most recent quarterly YOY earnings per share (EPS) growth. Both sales and earnings are critical factors in the success of a company. Therefore, ranking companies by only one growth metric makes a ranking susceptible to the accounting anomalies of that quarter (such as changes in tax law or...
Upgrades •$Avantor (AVTR.US)$: Citigroup Upgrades to Buy from Neutral - PT $28 •$丘奇&德懷特 (CHD.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $90) •$康菲石油 (COP.US)$: Erste Group Upgrades to Buy from Hold •$福特汽車 (F.US)$: Morgan Stanley Upgrades to Overweight from Equal Weight - PT $14 •$慧榮科技 (SIMO.US)$: Susquehanna Upgrades to Positive from Neutral - PT $108 •$沃爾瑪 (WMT.US)$...
Upgrades •$博格華納 (BWA.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43) •$Expensify (EXFY.US)$: BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20) •$Grab Holdings (GRAB.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $3 •$華利安 (HLI.US)$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95) •$摩根大通 (JPM.US)$: Berenberg Upgrades to Hold from Sell - PT ...
Upgrades •$德希尼布FMC (FTI.US)$: Societe Generale Upgrades to uy from Hold - PT $10 •$Lululemon Athletica (LULU.US)$: Truist Securities Upgrades to Buy from Hold - PT $495 (from $390) •$NorthWestern (NWE.US)$: Barclays Upgrades to Equal Weight From Underweight - PT $62 (from $57) •$波特蘭通用電氣 (POR.US)$: Barclays Upgrades to EqualWeight From Underweight - PT $57 (from $53) •$普爾斯瑪特 (PSMT.US)$: Scotiabank Upgrades to Sector Outperform Fro...
Penumbra股票討論
To be sure, drugs such as $諾和諾德 (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...
Gap Ups
1. $Vertiv Holdings (VRT.US)$ - up 18.6%
2. $伊瑞保險 (ERIE.US)$ - up 8.7%
3. $艾斯本科技 (AZPN.US)$ - up 6.5%
4. $潘世奇汽車 (PAG.US)$ - up 5.1%
5. $哈門那 (HUM.US)$ - up 3.7%
6. $梯瓦製藥 (TEVA.US)$ - up 3.7%
7. $Encompass Health (EHC.US)$ - up 3.0%
8. $艾默生電氣 (EMR.US)$ - up 2.8...
Both sales and earnings are critical factors in the success of a company. Therefore, ranking companies by only one growth metric makes a ranking susceptible to the accounting anomalies of that quarter (such as changes in tax law or...
• $Avantor (AVTR.US)$ : Citigroup Upgrades to Buy from Neutral - PT $28
• $丘奇&德懷特 (CHD.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $90)
• $康菲石油 (COP.US)$ : Erste Group Upgrades to Buy from Hold
• $福特汽車 (F.US)$ : Morgan Stanley Upgrades to Overweight from Equal Weight - PT $14
• $慧榮科技 (SIMO.US)$ : Susquehanna Upgrades to Positive from Neutral - PT $108
• $沃爾瑪 (WMT.US)$ ...
• $博格華納 (BWA.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43)
• $Expensify (EXFY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20)
• $Grab Holdings (GRAB.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $3
• $華利安 (HLI.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95)
• $摩根大通 (JPM.US)$ : Berenberg Upgrades to Hold from Sell - PT ...
• $德希尼布FMC (FTI.US)$ : Societe Generale Upgrades to uy from Hold - PT $10
• $Lululemon Athletica (LULU.US)$ : Truist Securities Upgrades to Buy from Hold - PT $495 (from $390)
• $NorthWestern (NWE.US)$ : Barclays Upgrades to Equal Weight From Underweight - PT $62 (from $57)
• $波特蘭通用電氣 (POR.US)$ : Barclays Upgrades to EqualWeight From Underweight - PT $57 (from $53)
• $普爾斯瑪特 (PSMT.US)$ : Scotiabank Upgrades to Sector Outperform Fro...
暫無評論